These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26905334)

  • 1. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
    Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
    Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition.
    Tanaka A; Muto S; Konno M; Itai A; Matsuda H
    Cancer Res; 2006 Jan; 66(1):419-26. PubMed ID: 16397257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment.
    Kinose Y; Sawada K; Makino H; Ogura T; Mizuno T; Suzuki N; Fujikawa T; Morii E; Nakamura K; Sawada I; Toda A; Hashimoto K; Isobe A; Mabuchi S; Ohta T; Itai A; Morishige K; Kurachi H; Kimura T
    Mol Cancer Ther; 2015 Apr; 14(4):909-19. PubMed ID: 25637316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.
    Yang M; Zou J; Zhu H; Liu S; Wang H; Bai P; Xiao X
    Oncol Rep; 2015 May; 33(5):2190-8. PubMed ID: 25760800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.
    Huang S; Robinson JB; Deguzman A; Bucana CD; Fidler IJ
    Cancer Res; 2000 Oct; 60(19):5334-9. PubMed ID: 11034066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.
    Assar EA; Vidalle MC; Chopra M; Hafizi S
    Tumour Biol; 2016 Jul; 37(7):9375-85. PubMed ID: 26779636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
    Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
    Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways.
    Ma K; Wang C; Geng Q; Fan Y; Ning J; Yang H; Dong X; Dong D; Guo Y; Wei X; Li E; Wu Y
    Oncol Rep; 2016 Jun; 35(6):3505-13. PubMed ID: 27035232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
    Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells.
    Uota S; Zahidunnabi Dewan M; Saitoh Y; Muto S; Itai A; Utsunomiya A; Watanabe T; Yamamoto N; Yamaoka S
    Cancer Sci; 2012 Jan; 103(1):100-6. PubMed ID: 21951590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IkappaB kinase beta restrains oncogenic proliferation of pancreatic cancer cells.
    Ochiai T; Saito Y; Saitoh T; Dewan MZ; Shioya A; Kobayashi M; Kawachi H; Muto S; Itai A; Uota S; Eishi Y; Yamamoto N; Tanaka S; Arii S; Yamaoka S
    J Med Dent Sci; 2008 Mar; 55(1):49-59. PubMed ID: 19845150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
    Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
    Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
    Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
    Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
    Oka D; Nishimura K; Shiba M; Nakai Y; Arai Y; Nakayama M; Takayama H; Inoue H; Okuyama A; Nonomura N
    Int J Cancer; 2007 Jun; 120(12):2576-81. PubMed ID: 17290398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IκB kinase-β inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice.
    Lennikov A; Hiraoka M; Abe A; Ohno S; Fujikawa T; Itai A; Ohguro H
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6365-73. PubMed ID: 25205865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma.
    Ogawa H; Azuma M; Muto S; Nishioka Y; Honjo A; Tezuka T; Uehara H; Izumi K; Itai A; Sone S
    Clin Exp Allergy; 2011 Jan; 41(1):104-15. PubMed ID: 20573155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin blocks IKKα activation and suppresses prostate cancer progression.
    Shukla S; Kanwal R; Shankar E; Datt M; Chance MR; Fu P; MacLennan GT; Gupta S
    Oncotarget; 2015 Oct; 6(31):31216-32. PubMed ID: 26435478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.
    Ataie-Kachoie P; Badar S; Morris DL; Pourgholami MH
    Mol Cancer Res; 2013 Oct; 11(10):1279-91. PubMed ID: 23858099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.